23andMe Holding Co. stock is up 19.63% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 3 PUTs, 1 CALL.
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The company was founded in 2006 and is headquartered in South San Francisco, California.